Centro Médico Teknon
Centro Médico Teknon
Spain, Barcelona
Joan Ramon Garces Gatnau
40 years of experience
Clinic is certified :
Psoriasis treatment cost in Spain typically involves a complex diagnosis of dermatological disease ranging from $200 to $400. While specific surgical procedures are uncommon, total annual management costs run from $1,100 for mild cases to over $18,000 for advanced biologic therapies. Prices depend on disease severity, medication type, and clinic tier. Patients can save approximately 30-50% compared to the US. Top cities include Barcelona and Madrid.
Typical Psoriasis Treatment Costs in Spain
Bookimed Expert Insight: Patients with complex or refractive psoriasis benefit most from JCI-accredited multidisciplinary centers. Clinica Universidad de Navarra, ranked among the World's Best Hospitals, serves over 140,000 international patients. For those seeking advanced research-based care, Quironsalud Madrid provides access to clinical trials. Barcelona's Centro Médico Teknon offers premium diagnostic services utilized by high-profile professional athletes. These top-tier Spanish hospitals provide significant value for patients requiring long-term biological therapy monitoring.
Dr. Luis Madero is a pediatric oncologist with 37 years of experience in treating blood disorders, bone marrow transplant, ablation therapy, and other diseases. He is a member of several associations and has extensive experience in his field.
Dr. Antonio Alcaraz is a Spanish uro-oncologist and transplantologist with over 30 years of experience and 500 successful operations, specializing in the treatment of prostate cancer, kidney, bladder, and other urogenital system pathologies using minimally invasive and robotic systems, as well as congenital pathologies in children. He is a member of several prestigious urological societies.
Dr. Rodrigo Rocamora Zuniga is a neurologist who specializes in epilepsy. He leads the epilepsy department at HM Delfos Hospital in Spain. He is also a professor at UPF University. Dr. Rocamora earned his PhD from Bonn University in 2001. He completed his neurology training at Pontificia Universidad Católica de Chile and received his medical degree in Mendoza, Argentina.
Dr. Rocamora is accredited by the European Reference Network. He is an active member of SEN, CSUR, and EPI-Care. He has published over 100 scientific articles on drug-resistant epilepsy, epilepsy surgery, and cognitive impairment. His work has helped develop new protocols that have improved care for epilepsy patients.